腹腔镜与开腹远端胰腺切除术对比(LAPOP):单中心、非盲法随机对照试验研究方案
LAPOP为前瞻性随机、非盲法、平行组、单中心优效性试验,计划纳入60例经多学科肿瘤委员会评估需手术切除的胰体或胰尾病变患者,随机接受腹腔镜远端胰腺切除术(LDP)或开腹远端胰腺切除术(ODP)。主要结局为术后住院时间,次要结局包括功能恢复、围手术期出血、并发症、镇痛药物需求及生活质量比较。该试验旨在检验LDP较ODP缩短术后住院时间的假设。
要点
- LAPOP为单中心、非盲法、平行组、前瞻性随机优效性试验,计划样本量60例。
- 纳入标准为经多学科肿瘤委员会评估需手术切除的胰体或胰尾病变患者。
- 主要结局为术后住院时间,次要结局包括功能恢复、围手术期出血、并发症、镇痛需求和生活质量。
核心结论
- LAPOP试验将检验腹腔镜远端胰腺切除术较开腹远端胰腺切除术缩短术后住院时间的假设。
研究设计与样本
- LAPOP为前瞻性随机、非盲法、平行组、单中心优效性试验,计划纳入60例经多学科肿瘤委员会评估需手术切除的胰体或胰尾病变患者,随机分配至LDP组或ODP组。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Earlier nonrandomized studies have suggested that laparoscopic distal pancreatectomy (LDP) is advantageous compared with open distal pancreatectomy (ODP) regarding hospital stay, blood loss, and recovery. Only one randomized study has been conducted showing reduced time to functional recovery after LDP compared with ODP. METHODS: LAPOP is a prospective randomized, nonblinded, parallel-group, single-center superiority trial. Sixty patients with lesions in the pancreatic body or tail that are found by a multidisciplinary tumor board to need surgical resection will be randomized to receive LDP or ODP. The primary outcome variable is postoperative hospital stay, and secondary outcomes include functional recovery (defined as no need for intravenous medications or fluids and as the ability of an ambulatory patient to perform activities of daily life), perioperative bleeding, complications, need for pain medication, and quality of life comparison. DISCUSSION: The LAPOP trial will test the hypothesis that LDP reduces postoperative hospital stay compared with ODP. TRIAL REGISTRATION: ISRCTN, 26912858 . Registered on 28 September 2015.
引用
- Björnsson B, Sandström P, Larsson AL, et al. Laparoscopic versus open distal pancreatectomy (LAPOP): study protocol for a single center, nonblinded, randomized controlled trial. Trials. 2019. PMID: 31196166. doi:10.1186/s13063-019-3460-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。